Related Experiment Video

Updated: Nov 28, 2025

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice
06:40

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

Published on: February 9, 2014

28.8K

The role of the cholinergic anti-inflammatory pathway in septic cardiomyopathy

Wenting Wang1, Hui Xu2, Huan Lin1

  • 1Department of Intensive Care Unit, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

International Immunopharmacology
|November 27, 2020
PubMed

Insights

Septic cardiomyopathy (SCM) is a serious condition. Activating the cholinergic anti-inflammatory pathway (CAP) via alpha7 nicotinic acetylcholine receptors (α7nAChR) shows promise for treating SCM by reducing inflammation and regulating immune responses.

Area of Science:

  • Cardiovascular Pathophysiology
  • Immunology
  • Neuroscience

Background:

  • Septic cardiomyopathy (SCM) is a frequent complication of sepsis, leading to cardiovascular failure and high mortality.
  • Current treatments for SCM are limited due to its complex pathogenesis.
  • The cholinergic anti-inflammatory pathway (CAP) regulates inflammatory responses.

Purpose of the Study:

  • To review the role of the cholinergic anti-inflammatory pathway (CAP) in attenuating inflammation in septic cardiomyopathy (SCM).
  • To discuss the potential of alpha7 nicotinic acetylcholine receptor (α7nAChR) activation in regulating immune responses and reducing inflammation in SCM.

Main Methods:

  • Literature review of studies on CAP, α7nAChR, and SCM.
  • Analysis of preclinical and clinical trial data regarding CAP activation in inflammatory diseases.
  • Examination of the mechanisms of acetylcholine (ACh) and α7nAChR in modulating inflammatory mediators and immune cells during sepsis.

Main Results:

  • CAP activation, particularly through α7nAChR, has demonstrated anti-inflammatory effects in experimental SCM.
  • α7nAChR activation inhibits inflammatory mediators and regulates immune cell function in sepsis.
  • Evidence suggests CAP plays a critical role in maintaining inflammatory-immune balance during sepsis.

Conclusions:

  • The cholinergic anti-inflammatory pathway (CAP) and its key component, α7nAChR, represent a promising therapeutic target for septic cardiomyopathy (SCM).
  • Targeting α7nAChR activation may offer a novel strategy to manage inflammation and immune dysregulation in SCM patients.
  • Further research into CAP modulation could lead to improved treatment outcomes for SCM.

Keywords:
Alpha7 nicotinic acetylcholine receptorAnti-inflammationCholinergic anti-inflammatory pathwayImmunitySeptic cardiomyopathy

More Related Videos

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System08:01

Semi-Minimal Invasive Method to Induce Myocardial Infarction in Rats and the Assessment of Cardiac Function by an Isolated Working Heart System

Published on: June 11, 2020

8.4K
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses06:43

Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses

Published on: March 29, 2017

10.2K

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
184
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
86
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
145
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
116
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
231
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
118